Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients

Cancer

Volumn 116, Issue 9, 2010, Pages 2242-2249

  Kilburn, Lindsay ^a,b   Okcu, M Fatih ^a,b   Wang, Tao ^a   Cao, Yumei ^b,c   Renfro Spelman, Amy ^b,c   Aldape, Kenneth D ^d   Gilbert, Mark R ^d   Bondy, Melissa ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Childhood Cancer Epidemiology and Prevention Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Anaplastic glioma; Glutathione S transferase polymorphisms; Pharmacogenetics; Survival

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADOLESCENT; ADULT; AGED; ANAPLASTIC GLIOMA; ARTICLE; CANCER RISK; CANCER SURVIVAL; CHROMOSOME 19Q; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENOTYPE; GLIOMA; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS;

EID: 77951476687     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25006     Document Type: Article

References (43)

1. Central Brain Tumor Registry of the United States (CBTRUS). Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Hinsdale, Ill: Central Brain Tumor Registry of the United States; 2005.
2. Brada M, Yung WK. Clinical trial endpoints in malignant glioma: need for effective trial design strategy. Semin Oncol. 2000;27:11-19. (Pubitemid 30390230)
3. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in 3 Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704-710. (Pubitemid 23133591)
4. Shapiro WR. Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol. 1986; 13:38-45.
5. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344: 114-123.
6. Scott JN, Rewcastle NB, Brasher PM, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol. 1999;46:183-188.
7. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473-1479. (Pubitemid 28482012)
8. Smith LM, Anderson JR, Qualman DJ, et al. Which patients with rhabdomyosarcoma (RMS) and microscopic residual tumor (Group II fail therapy? A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG) [abstract]. Proc Am Soc Clin Oncol. 2000;19:577a. Abstract 2273B.
9. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286:487-491.
10. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445-600. (Pubitemid 26016466)
11. Mannervik B, Danielson UH. Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem. 1988;23:283-337.
12. Berhane K, Hao XY, Egyhazi S, et al. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line. Cancer Res. 1993;53:4257-4261. (Pubitemid 24146775)
13. Ali-Osman F, Stein DE, Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea- resistant human malignant astrocytoma cell lines. Cancer Res. 1990;50:6976-6980. (Pubitemid 20361101)
14. Ali-Osman F, Brunner JM, Kutluk TM, et al. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res. 1997;3:2253-2261. (Pubitemid 28133143)
15. Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet. 1981;33:36-43.
16. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-1248. (Pubitemid 34027754)
17. Meyer DJ, Coles B, Pemble SE, et al. Theta, a new class of glutathione transferases purified from rat and man. Biochem J. 1991;274(pt 2):409-414.
18. Ali-Osman F, Akande O, Antoun G, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of 3 human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004-10012. (Pubitemid 27171673)
19. Hu X, Xia H, Srivastava SK, et al. Activity of 4 allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun. 1997;238:397-402. (Pubitemid 27464396)
20. Hu X, Herzog C, Zimniak P, et al. Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. Cancer Res. 1999;59:2358-2362. (Pubitemid 29242283)
21. Pandya U, Srivastava SK, Singhal SS, et al. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochem Biophys Res Commun. 2000;278:258-262.
22. Stanulla M, Schrappe M, Brechlin AM, et al. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood. 2000;95:1222-1228. (Pubitemid 30099830)
23. Anderer G, Schrappe M, Brechlin AM, et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics. 2000;10:715-726.
24. Davies SM, Bhatia S, Ross JA, et al. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002; 100:67-71. (Pubitemid 35177430)
25. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752-4758. (Pubitemid 40807300)
26. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol. 2001;19: 1279-1287. (Pubitemid 32202531)
27. Naoe T, Tagawa Y, Kiyoi H, et al. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia. 2002;16:203-208. (Pubitemid 34145137)
28. Mertens AC, Mitby PA, Radloff G, et al. XRCC1 and glutathione-S- transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer. 2004;101:1463-1472.
29. Okcu MF, Selvan M, Wang L, et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004;10:2618-2625. (Pubitemid 38509134)
30. Ambrosone CB, Sweeney C, Coles BF, et al. Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res. 2001;61:7130-7135. (Pubitemid 32946505)
31. Stoehlmacher J, Park DJ, Zhang W, et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002;94:936-942. (Pubitemid 34778092)
32. Lu C, Spitz MR, Zhao H, et al. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2005;106:441-447.
33. Holley SL, Rajagopal R, Hoban PR, et al. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer. Int J Oncol. 2006;28:231-236.
34. Goekkurt E, Hoehn S, Wolschke C, et al. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) - novel predictors for response and survival in gastric cancer patients. Br J Cancer. 2006;94:281-286. (Pubitemid 43151548)
35. Beebe D, Holmes E. Locatioin may not affect IQ and adaptive outcome in pediatric cerebellar tumors. J Int Neuropsychol Soc. 2002;8:293-294.
36. DeMichele A, Aplenc R, Botbyl J, et al. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. J Clin Oncol. 2005;23:5552-5559. (Pubitemid 46300149)
37. Lee JM, Wu MT, Lee YC, et al. Association of GSTP1 polymorphism and survival for esophageal cancer. Clin Cancer Res. 2005;11:4749-4753. (Pubitemid 41557194)
38. Sweeney C, Nazar-Stewart V, Stapleton PL, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2003;12:527-533.
39. Oldenburg J, Kraggerud SM, Cvancarova M, et al. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. J Clin Oncol. 2007;25:708-714. (Pubitemid 350002927)
40. Lecomte T, Landi B, Beaune P, et al. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy. Clin Cancer Res. 2006;12:3050-3056. (Pubitemid 43837350)
41. Hohaus S, Di RA, Di FA, et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res. 2005;11:2175-2179. (Pubitemid 40490175)
42. Srivastava SK, Singhal SS, Hu X, et al. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys. 1999;366:89-94. (Pubitemid 29394233)
43. Ishimoto TM, Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics. 2002;12:543-553. (Pubitemid 35177084)